Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Urethral insert approved for female stress incontinence

Sep. 6, 1996

Finasteride clinical utility continues to be debated

Sep. 6, 1996

Potential BPH therapy from Glaxo Wellcome

Sep. 6, 1996

5alpha-Reductase inhibitors for BPH

Sep. 6, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

OP-1 role in kidney formation investigated

Aug. 30, 1996

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Potential BPH therapeutics from Poli Industria Chimica

Aug. 30, 1996

U.S. agreement announced for ProstaFlo

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.